Celleration, Inc.
9
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
44.4%
4 terminated/withdrawn out of 9 trials
55.6%
-31.0% vs industry average
44%
4 trials in Phase 3/4
100%
5 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Healing Rate of Leg Wounds Treated With Contact and Noncontact Ultrasound: The VIP Ultrasound Protocol
Role: collaborator
MIST Ultrasound Therapy Compared to United Kingdom Standard Care for the Treatment of Non-healing Venous Leg Ulcers
Role: collaborator
Effects of Non Contact Low Frequency Ultrasound in Healing Venous Leg Ulcers
Role: lead
Deep Tissue Injury Treatment With MIST Therapy Versus Standard Care: REVERSE DTI Study
Role: lead
Split Thickness Donor Site Healing With MIST Study
Role: lead
Comparative Effectiveness Study of MIST Therapy Versus Negative Pressure Wound Therapy
Role: lead
RESPOND Restoring Equilibrium and Wound Stimulation to Promote Healing Of Non-healing DFUs
Role: lead
Effectiveness Study of MIST Therapy After Cosmetic Surgery Procedures of the Face and Body
Role: lead
MIST Therapy's Effectiveness in Wound Bed Preparation and Role of Bacterial Biofilm in Chronic, Non-healing Wounds
Role: collaborator
All 9 trials loaded